Adequate hematologic function Adequate hematologic function Acceptable liver, renal, hematologic and coagulation function Adequate hematologic, renal, and liver function The patient has adequate baseline hematologic function, as demonstrated by the following: Acceptable hematologic, renal and liver function as follows: Adequate hematologic status Adequate organ function, hematologic status, coagulation status, kidney function, and liver function as follows: Adequate hematologic function Hematologic (BM Function): Adequate hematologic function (unless abnormalities are related to NHL), defined as follows: Subject has adequate hematologic function and adequate hepatic function at screening Participant must have adequate hematologic, renal, and liver function laboratory values as described in the protocol. Hematologic (BM Function): Adequate kidney and hematologic function assessed from baseline laboratory data Have adequate hematologic function. Adequate hematologic function: Adequate hematologic function Adequate hematologic function Adequate hematologic function Inclusion Criteria:\n\n Patients with histologically or cytologically confirmed advanced solid malignancy or\n Lymphoma\n\n Relapsed or refractory disease after at least 1 prior systemic treatment for the primary\n malignancy and not a candidate for other curative treatment.\n\n Adequate hematologic status\n\n Adequate coagulation function\n\n Adequate hepatic function\n\n Adequate renal function\n\n Exclusion Criteria:\n\n Known primary tumors of central nervous system disease\n\n Known active brain metastases\n\n Known cardiopulmonary disease Adequate hematologic function: Adequate renal, and hematologic function Adequate hematologic function Adequate baseline hematologic function, as demonstrated by the following: Adequate hematologic status Adequate hematologic function: Adequate hematologic function as defined by: Adequate hematologic, renal and liver function Adequate hematologic function Must have adequate hematologic, renal, and liver function Patients must be suitable candidates for treatment with standard regimens; this includes having adequate hematologic parameters, liver function and renal function based on labs that are deemed acceptable for treatment by the investigators Adequate hematologic function, as defined by the following criteria: Adequate hematologic function. Adequate hematologic function: Adequate hematologic function defined by: Adequate hematologic function Adequate hematologic, liver, coagulation, renal, and cardiovascular function Hematologic function, as follows: Adequate hematologic, renal and liver function Adequate hematologic, liver, and renal function Hematologic, liver, and renal function as specified in the study protocol. Has adequate hematologic, liver, and renal function Adequate hematologic and renal function as determined by laboratory blood and urine tests Adequate hematologic function. Adequate hematologic function as indicated by: Adequate hematologic, immunologic, liver and renal function, defined as Adequate hepatic and renal function Must have adequate hepatic, renal, cardiac and hematopoietic function Insufficient hepatic and renal function. Adequate renal and hepatic function Hepatic and renal function Adequate renal and hepatic function: Adequate renal and hepatic function, per laboratory reference range at screening Adequate renal, hepatic, pulmonary and cardiac function defined as: Renal function and Hepatic function Adequate renal and hepatic function as defined: Adequate organ function, including renal and hepatic function based on the last assessment performed within the Screening Period Patients enrolled in the Dose Finding Portion of the Study: Adequate renal, hepatic, cardiac, and pulmonary function as evidenced by: DONOR: Cardiac, renal, pulmonary, and hepatic function within normal limits Adequate renal and hepatic function: Adequate hepatic and renal function Adequate renal and hepatic function: Adequate hematopoietic capacity, hepatic and renal function Has protocol-defined adequate renal, hepatic and cardiac status Adequate renal and hepatic function: Adequate hepatic and renal function (these must be WNL or verified by study chair to be related to conditions not interfering with normal health status) Adequate baseline renal and hepatic function Adequate hepatic and renal function defined as: The patient has adequate baseline organ function, including cardiac, renal, and hepatic function: The patient has adequate baseline organ function, including cardiac, renal, and hepatic function: Has protocol-defined adequate cardiac, renal and hepatic function Adequate renal and hepatic function defined as: Adequate hepatic, and renal function Adequate Blood, renal and hepatic function, as determined within 28 days from registration: Adequate renal and hepatic function Adequate hepatic and renal function Adequate renal, hepatic and pancreatic function Adequate hepatic and renal function defined as: Adequate coagulation, renal and hepatic function Adequate renal and hepatic function Adequate renal, hepatic, pulmonary and cardiac function defined as: Adequate hepatic and renal function: Seriously limited cardiac, renal, or hepatic function Subject must have adequate coagulation profile, renal, and hepatic function, per laboratory reference range at Screening Adequate hepatic, renal and pancreatic function. Adequate renal and hepatic function Adequate renal and hepatic function. Subject must have adequate coagulation, renal, and hepatic function, per laboratory reference range at Screening. Adequate coagulation, renal and hepatic function Have adequate blood counts, hepatic and renal function Subject must have adequate coagulation, renal, and hepatic function, per laboratory reference range at Screening. Subject must have adequate coagulation, renal, and hepatic function, per laboratory reference range at Screening. Adequate hepatic and renal function within protocol-defined parameters. Adequate hepatic and renal function Adequate baseline renal and hepatic function Adequate pulmonary, renal, hepatic, and cardiac function Adequate baseline renal and hepatic function Adequate hepatic and renal function defined as: have adequate hepatic function and renal function Adequate renal and hepatic function, as defined by the following criteria: Adequate renal, hepatic, pulmonary and cardiac function defined as: Adequate baseline renal and hepatic function Adequate hepatic, renal, and cardiac function Renal and Hepatic Function Adequate hepatic and renal function defined as: Adequate hepatic and renal function: No prior anticancer therapy for pancreatic cancer •? 18 years of age with a performance status of 0 or 1•Adequate complete blood counts, hepatic function, and renal function Have renal and hepatic function as defined by: Renal and Hepatic Function: Patient must have adequate renal and hepatic functions as indicated by the following laboratory values: Adequate renal and hepatic function Adequate baseline renal and hepatic function Adequate renal and hepatic function and hematopoietic capacity Adequate hepatic and renal function The patient has adequate organ function, including cardiac, renal, and hepatic function: Evidence of laboratory abnormalities in standard renal, hepatic, or coagulation function tests Adequate hepatic and renal function Adequate hepatic and renal function adequate renal, hepatic and pancreatic function Adequate hepatic and renal function defined as: Adequate hepatic and renal function defined as: Adequate renal and hepatic function Have adequate hematopoietic, hepatic, and renal function at a screening visit Adequate renal, hepatic, cardiac, and pulmonary function as evidenced by: Has adequate renal and hepatic function Adequate hematologic, renal, and hepatic parameters Adequate hematologic parameters unless clearly due to the disease under study Adequate hematologic, renal and hepatic laboratory parameters Adequate hematologic parameters without ongoing transfusional support: Adequate hematologic parameters without ongoing transfusional support: Adequate hematologic parameters without ongoing transfusional support: Adequate renal, hepatic, and hematologic functions per protocol-defined laboratory parameters within ? 7 days before treatment initiation. Adequate hematologic function within protocol-defined parameters. Subject has the following laboratory parameters at screening: Adequate hematologic function including: Patient has any of the following hematologic parameters: Hematologic parameters must be assessed at least 14 days after a prior transfusion, if any Hematologic parameters defined by: Inadequate organ or bone marrow function Inadequate hematologic function as evidenced by any of the following: Inadequate liver function as evidenced by any of the following: Inadequate bone marrow function Inadequate renal function as defined by serum creatinine > 3x normal for age Inadequate performance status/organ function. Inadequate performance status/organ function. Participants with prior Hepatitis B or C infection with inadequate liver function Impaired hepatic or renal function, inadequate bone marrow reserve or organ function, Cardiac dysfunction Inadequate liver function at screening as demonstrated by the following: Inadequate pulmonary function Inadequate marrow function in cohort 1: Inadequate marrow function in cohort 2:\r\n* These patients will not have marrow function criteria Inadequate liver, renal function as defined below for both cohorts: An inadequate tumor specimen as defined by the local pathologist Unstable/inadequate cardiac function: Inadequate washout from prior therapy Evidence of inadequate renal function (creatinine > 2 g/dL) Inadequate bone marrow or organ function Inadequate performance status/ organ function Inadequate organ function, evidenced by the following laboratory results: Pregnancy or inadequate contraception. have inadequate organ function per protocol Inadequate lung function Inadequate hepatic function Inadequate renal function Inadequate bone marrow function Inadequate organ function per protocol-specified total bilirubin, AST and ALT, creatinine clearance and alkaline phosphatase. Inadequate organ function including: Unstable/inadequate cardiac function: Inadequate organ function including: Inadequate organ function including: Inadequate hematologic function (unless due to underlying lymphoma) Inadequate organ function Inadequate hematologic, renal, and liver function (unless due to underlying lymphoma) Inadequate renal or liver function Inadequate hematological, liver, renal, cardiac function Has a history or presence of inadequate liver, renal, hematopoietic and/or cardiac function parameters outside protocol-defined range Inadequate hematologic function, renal function, and liver function Subject has inadequate marrow, hepatic, and/or renal function at the Screening Visit defined as: Inadequate hematologic or hepatic function Inadequate liver, renal or bone marrow function within 2 weeks of first dose Inadequate renal function Inadequate renal function Inadequate bone marrow, renal, or liver function Inadequate bone marrow function or evidence of end-organ damage Inadequate hematologic, renal or liver function Inadequate organ function as described Inadequate hematologic, renal or liver function Inadequate bone marrow, renal, or hepatic function as defined above, or an active coagulopathy that precludes tissue biopsy E 17. Inadequate organ and bone marrow function Inadequate liver function at screening and Day 1 (before drug administration) as demonstrated by: Abnormal/inadequate blood values, liver and kidney function abnormal/inadequate blood values, liver, and kidney function Inadequate cardiac function Inadequate heart function Inadequate lung function Inadequate renal, hepatic or bone marrow function Inadequate renal function (Blood creatinine > 1.5 times the institutional ULN) Inadequate hematopoietic, liver, endocrine or renal function Inadequate lung function Inadequate heart function Inadequate hematologic or biologic function as determined by the following laboratory tests: Inadequate organ and bone marrow function as evidenced by: Inadequate bone marrow or other organ function (excluding hepatic impairment per eligibility criteria). An inadequate tumor specimen as defined by the central pathologist. Inadequate organ function as defined on laboratory tests Inadequate lung function Inadequate hematologic, biochemical, and organ function Subject's laboratory results indicate inadequate organ function Adequate hematological function unless inadequate function is due to underlying disease Inadequate hematologic, liver, or renal function Inadequate hematological, biochemical or organ function Inadequate kidney, liver, blood clotting function Inadequate blood count Inadequate hematologic function as evidenced by any of the following: Inadequate liver function as evidenced by any of the following: Inadequate housing arrangements Inadequate hemostasis Inadequate hepatic function Inadequate renal function Inadequate bone marrow function Adequate hematologic, hepatic, and renal function Subject must have adequate hematologic, renal and hepatic function. Participants must have adequate hematologic, renal and hepatic function. Adequate hepatic, renal, cardiac, and hematologic function Poor hematologic, renal, or hepatic function Adequate hematologic, renal, and hepatic function Adequate hematologic, hepatic, and renal function. adequate hematologic, renal and hepatic function Poor hematologic, renal, or hepatic function Inadequate hematologic, renal or hepatic function. Adequate hepatic, renal, cardiac, and hematologic function. Must have adequate hematologic, renal and hepatic function. Adequate organ function as per Hematologic, Hepatic, Renal and Cardiac Laboratory Values Adequate hematologic, hepatic, and renal function Subjects must have adequate hematologic, hepatic and renal function. Adequate baseline hematologic, renal, and hepatic function Has adequate hematologic (bone marrow [BM] and coagulation factors), renal and hepatic function as defined by criteria below: Adequate hematologic, hepatic, and renal function Adequate baseline hematologic, renal, and hepatic function Adequate hematologic, coagulation (INR 2-3 max), hepatic and renal function Inadequate hematologic, coagulation (INR >3), hepatic, renal function Adequate hematologic, renal and hepatic function Adequate hepatic, renal, cardiac, and hematologic function Adequate hematologic, renal, and hepatic function. Adequate hematologic, hepatic, renal, and coagulation function. Has adequate hematologic (bone marrow and coagulation factors), renal and hepatic function as defined by criteria below: Participant must have adequate hematologic, renal, hepatic, and lung function. Adequate hematologic, renal, and hepatic function (within 28 days of randomization). Adequate hematologic, renal, and hepatic function Adequate hematologic, renal, and hepatic function Adequate hematologic, hepatic, and renal function Inadequate hematologic, hepatic, or renal function Has adequate hematologic (bone marrow [BM] and coagulation factors), renal and hepatic function Adequate hematologic, renal, and hepatic function determined by laboratory blood and urine tests. Has adequate hematologic (bone marrow and coagulation factors), renal, and hepatic function as defined by criteria below: Adequate hematologic, hepatic, and renal function Adequate hematologic, renal and hepatic function, specifically: Adequate renal, hepatic, and hematologic indices for ipilimumab therapy Inadequate hematologic, renal, or hepatic function Adequate hematologic, hepatic, and renal function Subject has adequate hematologic, hepatic, renal, and coagulation function Adequate organ function as per pre-defined hematologic, hepatic, renal, and cardiac criteria. Adequate hepatic, renal, cardiac, and hematologic function Adequate hepatic, hematologic, and renal function Adequate hematologic, hepatic, and renal function, defined by: Adequate hematologic, hepatic, and renal function Grossly normal pulmonary, cardiac function, renal, hepatic hematologic and performance functions Adequate hematologic, renal and hepatic function. Has adequate hematologic, hepatic, and renal function as defined by the protocol Adequate hematologic, hepatic, renal and cardiac function. Adequate hematologic, hepatic and renal function Adequate renal, hepatic, and hematologic indices for ipilimumab therapy Have adequate hematologic, hepatic, and renal function Have adequate hematologic, hepatic and renal function Adequate hematologic, hepatic and renal function. Adequate hematologic, hepatic, and renal function Has adequate hematologic, renal, cardiac and hepatic function. Adequate hematologic, hepatic, and renal function. Adequate hematologic, hepatic, cardiac, and renal function Adequate hematologic, hepatic, and renal function. Not adequate hematologic, renal and hepatic function Adequate hematologic, renal, and hepatic function. Adequate hematologic, hepatic, renal function Poor hematologic, renal, or hepatic function Adequate hematologic, hepatic, and renal function: Adequate baseline hematologic, pulmonary, renal, and hepatic function Adequate hematologic, hepatic and renal function Adequate hematologic, renal and hepatic function Adequate hematologic, renal and hepatic function Subject must have adequate hematologic, renal and hepatic function as follows: Adequate hematologic, hepatic and renal function Inadequate hematologic, hepatic or renal function Adequate hepatic, renal, cardiac and hematologic function Adequate hematologic, hepatic and renal function as defined by laboratory assessment Has adequate hematologic, coagulation, hepatic and renal function Adequate hematologic function, hepatic function, renal function and coagulation function Participants with adequate hematologic, hepatic, and renal function. Participant must have adequate hematologic, renal, and hepatic function. Patient has adequate hematologic, hepatic, and renal function as defined by: Adequate hepatic, renal, cardiac, and hematologic function Adequate hematologic, hepatic, and renal function, as evidenced by: Adequate hematologic, hepatic, and renal function Adequate hematologic, hepatic, and renal function.